Compare Bath & Body Works Inc (BBWI) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Inovio Pharmaceuticals Inc — how do they compare? Bath & Body Works Inc trades at $19 (market cap $3.81B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Bath & Body Works Inc is far larger — about 48.5× Inovio Pharmaceuticals Inc's market cap, and Bath & Body Works Inc pays a 4.24% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BBWI | INO | |
|---|---|---|
Market Cap | $3.81B | $78.55M |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $2.87 |
52-Week Low | $14.85 | $0.66 |
Enterprise Value | $7.70B | $49.56M |
Dividend Yield | 4.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
